Published in J Immunol on March 01, 1977
Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody. Infect Immun (1979) 1.94
Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans. Proc Natl Acad Sci U S A (1978) 1.35
Immune response to herpes simplex virus infections: virus-specific antibodies in sera from patients with recurrent facial infections. Infect Immun (1981) 1.11
Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B. J Virol (2008) 1.04
Replication of herpes simplex virus type 1 in macrophages from resistant and susceptible mice. Infect Immun (1979) 1.02
Use of protein A-treated sera in unmasking herpes simplex virus type 1 (HSV-1) immunoglobulin A and identifying HSV-1 immunoglobulin G as the predominant neutralizing antibody. J Clin Microbiol (1979) 1.01
Delayed hypersensitivity to herpes simplex virus: murine model. Infect Immun (1982) 0.99
Enumeration of viral antigen-reactive helper T lymphocytes in human peripheral blood by limiting dilution for analysis of viral antigen-reactive T-cell pools in virus-seropositive and virus-seronegative individuals. J Clin Microbiol (1989) 0.98
Reactivation of latent herpes simplex virus infection of the autonomic nervous system by postganglionic neurectomy. Infect Immun (1978) 0.98
Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs. Infect Immun (1980) 0.97
Virus-specific antibodies in sera from patients with genital herpes simplex virus infection. Infect Immun (1982) 0.94
Serum antibodies to herpes simplex virus type 1 during active oral herpes infection. Infect Immun (1980) 0.90
Immune responses in mice against herpes simplex virus: mechanisms of protection against facial and ganglionic infections. Infect Immun (1981) 0.88
Cellular and humoral immune responses to herpes simplex virus during and after primary gingivostomatitis. Infect Immun (1978) 0.88
Immune responses to herpes simplex virus in patients with recurrent herpes labialis: I. Development of cell-mediated cytotoxic responses. Clin Exp Immunol (1986) 0.88
Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy. Infect Immun (1981) 0.86
Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections. Clin Exp Immunol (1989) 0.85
[The lymphocyte transformation test in patients with recurrent herpes simplex diseases (author's transl)]. Arch Dermatol Res (1978) 0.84
Lymphocyte-derived chemotactic factor synthesis in initial genital herpesvirus infection: correlation with lymphocyte transformation. Infect Immun (1980) 0.78
Biosynthetic human interferon treatment of herpetic keratitis. Trans Am Ophthalmol Soc (1983) 0.75
Chitosan as an Immunomodulating Adjuvant on T-Cells and Antigen-Presenting Cells in Herpes Simplex Virus Type 1 Infection. Mediators Inflamm (2016) 0.75
Vaccination for herpes simplex genitalis. Br J Vener Dis (1979) 0.75
Correlation of herpes simplex virus antibody titers and specific lymphocyte stimulation in adult blood donors. J Clin Microbiol (1981) 0.75
Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med (1981) 5.44
Genetics of natural resistance to herpesvirus infections in mice. Nature (1975) 3.18
The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses. Arch Virol (1992) 3.09
Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides. J Med Chem (1979) 2.80
Circulating polyribophosphate in Hemophilus influenzae, type b meningitis. Correlation with clinical course and antibody response. J Clin Invest (1975) 2.48
Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions. Blood (1999) 2.22
Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med (1987) 2.17
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biol Blood Marrow Transplant (2013) 2.04
2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent. Antimicrob Agents Chemother (1980) 1.96
Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody. Infect Immun (1979) 1.94
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
An indirect fluorescent-antibody technique for study of uncomplicated gonorrhea. I. Methodology. J Infect Dis (1973) 1.75
Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet (1981) 1.70
Characterization of a new primary human pancreatic tumor line. Cancer Invest (1986) 1.67
Secretory IgA antibodies in the urethral exudate of men with uncomplicated urethritis due to Neisseria gonorrhoeae. J Infect Dis (1973) 1.65
Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood (1986) 1.60
Treatment of Diamond-Blackfan anemia with recombinant human interleukin-3. Blood (1993) 1.58
Segregation o co-transduced streptomycin and tetracycline resistance in Staphylococcus aureus. Genet Res (1972) 1.52
Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts. Blood (1989) 1.52
Toward an ecosocial view of health. Int J Health Serv (1999) 1.47
Accuracy of magnetic resonance imaging of inguinofemoral lymph nodes in vulval cancer. Int J Gynecol Cancer (2006) 1.47
Secretory IgA antibody responses to Neisseria gonorrhoeae in the genital secretions of infected females. J Infect Dis (1976) 1.46
Isolation of a virus from the lungs of Montana sheep affected with progressive pneumonia. Virology (1968) 1.46
An indirect fluorescent-antibody technique for study of uncomplicated gonorrhea. II. Selection and characterization of the strain of Neisseria gonorrhoeae used as antigen. J Infect Dis (1973) 1.41
Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virus-induced lymphoproliferations in xenografted C.B-17 scid/scid mice. Transplantation (1996) 1.40
Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med (1990) 1.38
Histology and prevalence of ovarian tumours in postmenopausal women: is follow-up required in all cases? J Obstet Gynaecol (2012) 1.38
Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets. J Immunol (1983) 1.37
Allogenic bone marrow transplantation: current status and future directions. Blood (1983) 1.36
Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg (1974) 1.34
Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation (1987) 1.31
1,000 consecutive ultrasounds for blunt abdominal trauma. J Trauma (1996) 1.31
Facilitation or attenuation of mixed leukocyte culture responsiveness by adherent cells. Nature (1976) 1.31
Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med (1982) 1.30
Joint transduction of separate extrachromosomal drug resistance determinants in Staphylococcus aureus E169. Biochem Biophys Res Commun (1971) 1.27
The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation. Blood (1996) 1.26
Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection. Hepatology (1998) 1.26
High-level transient expression of influenza virus proteins from a series of SV40 late and early replacement vectors. Gene (1988) 1.24
Role of virus infections in immunosuppressed renal transplant patients. Transplant Proc (1973) 1.23
Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity. J Clin Invest (1986) 1.23
Growth properties of human herpesvirus-6 strain Z29. J Virol Methods (1989) 1.23
Identification of a nucleocapsid protein as a specific serological marker of human herpesvirus 6 infection. J Clin Microbiol (1990) 1.23
Fracture of the outlet strut of a Björk-Shiley mitral prosthesis: emergency operation with survival. J Thorac Cardiovasc Surg (1984) 1.23
Role of interferon in natural kill of HSV-1-infected fibroblasts. J Immunol (1982) 1.22
Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native, unmodified cytomegalovirus globulin. Randomized trial in bone marrow transplant recipients. Am J Med (1984) 1.21
Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis. Biol Blood Marrow Transplant (1997) 1.19
Correlation between low natural killing of fibroblasts infected with herpes simplex virus type 1 and susceptibility to herpesvirus infections. J Infect Dis (1983) 1.19
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood (2000) 1.19
Recurrent Salmonella typhimurium bacteremia associated with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.17
Resistance to herpes simplex virus - type 1 (HSV-1). Curr Top Microbiol Immunol (1981) 1.17
Severe acquired immune deficiency syndrome in male homosexuals: diminished capacity to make interferon-alpha in vitro associated with severe opportunistic infections. J Infect Dis (1983) 1.16
Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur Radiol (2010) 1.15
Efficacy and selectivity of some nucleoside analogs as anti-human cytomegalovirus agents. Antimicrob Agents Chemother (1983) 1.14
Rationale for combined use of fetal liver and thymus for immunological reconstitution in patients with variants of severe combined immunodeficiency. Proc Natl Acad Sci U S A (1977) 1.13
The noncoding region of HPV-6vc contains two distinct transcriptional enhancing elements. Virology (1986) 1.12
Papovavirus excretion following marrow transplantation: incidence and association with hepatic dysfunction. Transplant Proc (1981) 1.12
Resistance to HSV-1 in the mouse is governed by two major, independently segregating, non-H-2 loci. Immunogenetics (1980) 1.12
Vestibular syndrome: a change in internal spatial representation. Neurophysiol Clin (2008) 1.09
Human natural killer cells limit replication of herpes simplex virus type 1 in vitro. J Immunol (1985) 1.09
Traumatic pseudoaneurysm of the left ventricle. Am J Dis Child (1970) 1.08
Human mononuclear cells which produce interferon-alpha during NK(HSV-FS) assays are HLA-DR positive cells distinct from cytolytic natural killer effectors. J Leukoc Biol (1988) 1.07
Marrow transplantation for juvenile osteopetrosis. Am J Med (1981) 1.07
Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir. Transpl Infect Dis (2007) 1.07
Marrow-dependent cells depleted by 89Sr mediate genetic resistance to herpes simplex virus type 1 infection in mice. Infect Immun (1980) 1.06
Thermodynamic analysis of calcium and magnesium binding to calmodulin. Biochemistry (1998) 1.05
Antileukemia activity of a natural killer cell line against human leukemias. Clin Cancer Res (1998) 1.05
M241 (CD1) expression on B lymphocytes. J Immunol (1987) 1.04
Isolation of Aleutian mink disease virus by affinity chromatography. Science (1973) 1.04
Immediate-early gene expression is sufficient for induction of natural killer cell-mediated lysis of herpes simplex virus type 1-infected fibroblasts. J Virol (1991) 1.04
Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood (2000) 1.03
Immunological nature of genetic resistance of mice to herpes simplex virus type 1 infection. IARC Sci Publ (1978) 1.03
Quantitation of T lymphocytes in human bone marrow by a limiting dilution assay. Transplantation (1985) 1.03
Replication of herpes simplex virus type 1 in macrophages from resistant and susceptible mice. Infect Immun (1979) 1.02
Pseudoaneurysm of the left ventricle following mitral valve replacement. Chest (1972) 1.02
Rapid selection of antigen-specific T lymphocytes by retroviral transduction. Blood (2000) 1.01
Oxidative stress and activation of proteasome protease during serum deprivation-induced apoptosis in rat hepatoma cells; inhibition of cell death by melatonin. Apoptosis (2003) 1.01
Absence of interleukin 2 production in a severe combined immunodeficiency disease syndrome with T cells. J Exp Med (1990) 1.01
Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease. Bone Marrow Transplant (2007) 1.01
Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms. Blood (1989) 1.01
Hyperfractionated total body irradiation for bone marrow transplantation. Results in seventy leukemia patients with allogeneic transplants. Int J Radiat Oncol Biol Phys (1983) 1.01
Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia. N Engl J Med (1987) 1.01
Studies of the cell lineage of the effector cells that spontaneously lyse HSV-1 infected fibroblasts (NK(HSV-1)). J Immunol (1982) 1.00
Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells. Proc Natl Acad Sci U S A (1989) 0.99
Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. Br J Haematol (2000) 0.99
Cell-mediated and humoral immune responses or renal transplant recipients with cytomegalovirus infections. Clin Exp Immunol (1974) 0.98
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT. Bone Marrow Transplant (2010) 0.98
Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis (2007) 0.98
N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age. Med Pediatr Oncol (2001) 0.98
The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations. Blood (1993) 0.97
DNA dendrimers localize MyoD mRNA in presomitic tissues of the chick embryo. J Cell Biol (2000) 0.97
Accidental high-pressure injection-gun injuries of the hand; the role of the emergency radiologic examination. J Trauma (1975) 0.97